Experimental drug may protect the heart in Duchenne muscular dystrophy

Researchers at the USF Health Morsani College of Medicine have identified a potential pathway that could protect cardiac function in people with Duchenne muscular dystrophy (DMD), a progressive and fatal genetic disease that weakens the body's muscles.

Published in Molecular Therapy, the new study examined the effects of the experimental drug Setanaxib in two preclinical models of DMD. ...